Cryolab Publishes Clinical Guide to Egg Freezing Outcomes and Vitrification Technology in 2026

WEST SUSSEX, U.K. - Rezul -- UK cryogenic equipment specialist addresses critical knowledge gap between egg freezing consultation and laboratory reality

CHICHESTER, UK, August 28, 2026 -- Cryolab Ltd, the UK's leading specialist supplier of IVF laboratory and cryogenic equipment, has published a comprehensive clinical resource examining the science behind egg freezing outcomes in 2026, with particular focus on what happens to oocytes between collection and warming -- the phase of treatment that most patient-facing information fails to address.

The guide, published at cryolab.co.uk, draws on the largest US outcome study to date -- published in Fertility and Sterility by researchers at NYU Langone -- which found that 70 percent of women who froze eggs under the age of 38 and subsequently thawed at least 20 eggs achieved a live birth. The resource contextualises these findings within the current UK regulatory framework, HFEA storage requirements, and the laboratory infrastructure that determines whether clinical outcomes match the evidence.

Paul Hague, Director of Cryolab and a 42-consecutive-meeting attendee at ESHRE, commented: "Vitrification has transformed egg freezing from an experimental procedure into standard clinical practice. But the outcome depends on laboratory quality, storage reliability, and warming skill as much as it depends on the number of eggs retrieved. That second half of the story is what we have written for."

More on Rezul News

• Goldshine Management Consulting Announces Multifamily Management Challenges and Opportunities Survey
• £1m Cambridge home on the birthplace of Lister racing cars comes to market
• PulteGroup opens new model, now selling at Joseph Oaks
• Prime Painting & Services LLC in Fort Collins Named in Allegations Involving Mobile Home Wire Fraud
• Moore Roofing Company Explains Why Hiring A Local Roofer Matters

The guide covers vitrification technique and post-warming survival rates, the critical role of liquid nitrogen storage infrastructure in long-term oocyte preservation, the HFEA regulatory framework including the 55-year maximum storage provision, and the questions patients should ask before proceeding with egg freezing.

With egg freezing volumes increasing year on year across the UK and IVF success rates from frozen embryo transfers reaching an all-time high of 39 percent per transfer cycle, Cryolab identified a significant information gap between what clinics discuss in consultations and what patients understand about the laboratory and storage phase of treatment.

The full guide is available at: https://cryolab.co.uk/egg-freezing-2026-science-vitrification/

About Cryolab Ltd: Cryolab is a UK-based specialist supplier of IVF laboratory and cryogenic equipment, established in 2000 by Paul Hague. The company holds ISO 9001:2015 BSI Quality Management System certification and operates as the exclusive UK and Ireland distributor for CryoBioSystems (a brand of ART). Cryolab supplies NHS hospitals, private fertility clinics, biobanks, and research facilities across the UK and internationally.